Skip to Main Navigation Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

We welcome your feedback!

Contact us with your comments.

 
of 1

Refine

  • Categories
  • Content Type
  • Reports and Publications
  • Years
  • Formats


9 results found for "52485-79-7".
  1. Presentation: ICCVAM Evaluation and Recommendations on Best Practices... 557KB

    https://ntp.niehs.nih.gov/iccvam/meetings/implement-2011/ocular-present/5-stokesaahe.pdf

    ... - Administer 0.01 mg/kg buprenorphine subcutaneously to provide a ... Administer Rescue Dose . 0.03 mg/kg buprenorphine and 0.5 mg/kg meloxicam subcutaneously ...

  2. Report of Ocular Peer Review Panel Meeting (2009) 947KB

    https://ntp.niehs.nih.gov/iccvam/docs/ocutox_docs/ocularprprept2009.pdf

    ... Sixty minutes pre-test substance application (TSA) Buprenorphine 0.01 mg/kg by subcutaneous injection (SC) Rationale: Buprenorphine is classified as an opioid agonist-antagonist ...

  3. Presentation: Alternative Test Methods for Ocular Hazard Assessment... 2.8MB

    https://ntp.niehs.nih.gov/iccvam/meetings/implement-2011/ocular-present/12-casestudiesresultssummary.pdf

    ... Buprenorphine 0.01 mg/kg by subcutaneous injection (SC) to provide a therapeutic level of ... nonsteroidal anti-inflammatory drug - Buprenorphine 0.01 mg/kg by subcutaneous injection ...

  4. Presentation: In Vitro In Vivo Extrapolation and its Applications... 2.4MB

    https://ntp.niehs.nih.gov/iccvam/meetings/ivive-wksp-2016/wksp-ppts/3-2-ke-508.pdf

    ... Maturation of Biliary Clearance Appears to be Rapid Azithromycin Ceftriaxone Digoxin Buprenorphine Johnson et al Drug Metab Dispos. 2016 © Copyright 2013 Certara, L.P. All rights ...

  5. ICCVAM Test Method Evaluation Report: Low Volume Eye Test 2.8MB

    https://ntp.niehs.nih.gov/iccvam/docs/ocutox_docs/lvet/tmer-all.pdf

    ... Pretreatment Analgesia: Buprenorphine 0.01 mg/kg subcutaneous (SC) (60 minutes before test substance application [TSA]). Dr. Sawyer noted that buprenorphine is classified as an ...

  6. Minutes: SACATM; June 25, 2009 361KB

    https://ntp.niehs.nih.gov/sites/default/files/ntp/about_ntp/sacatm/2009/june/minutes20090625.pdf

    ... Hayes about the Panel's specific recommendation for the use of the analgesic buprenorphine... Nicolaysen asked why the Panel recommended the dose of 0.01 mg/kg buprenorphine, which is ...

  7. ICCVAM Test Method Evaluation Report: Ocular Hazard Testing Strategy... 4.3MB

    https://ntp.niehs.nih.gov/iccvam/docs/ocutox_docs/amcp/tmer-all.pdf

    ... Pretreatment Analgesia: Buprenorphine 0.01 mg/kg subcutaneous (SC) (60 minutes before test substance application [TSA]). Dr. Sawyer noted that buprenorphine is classified as an ...

  8. ICCVAM Test Method Evaluation Report: In Vitro Test Methods for... 34.8MB

    https://ntp.niehs.nih.gov/iccvam/docs/ocutox_docs/invitro-2010/tmer-vol2.pdf

    ... Pretreatment Analgesia: Buprenorphine 0.01 mg/kg subcutaneous (SC) (60 minutes before test substance application [TSA]). Dr. Sawyer noted that buprenorphine is classified as an ...

  9. CERHR Monograph: Potential Human Reproductive and Developmental... 6.3MB

    https://ntp.niehs.nih.gov/ntp/ohat/bisphenol/bisphenol.pdf

    ... to adults, glucuronidation activity was lower for ibuprofen (24- fold), amitriptyline (16-fold), 4-tert-butylphenol (40-fold), estrone (15-fold), and buprenorphine (12-fold). ...

 
of 1